Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study (MD-CHINA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03335943
Recruitment Status : Unknown
Verified November 2017 by Wu Depei, Chinese Society of Hematology.
Recruitment status was:  Not yet recruiting
First Posted : November 8, 2017
Last Update Posted : November 8, 2017
Sponsor:
Collaborator:
Harbin Institute of Hematology & Oncology
Information provided by (Responsible Party):
Wu Depei, Chinese Society of Hematology